183 related articles for article (PubMed ID: 31196778)
41. Contraception after medication abortion in the United States: results from a cluster randomized trial.
Rocca CH; Goodman S; Grossman D; Cadwallader K; Thompson KMJ; Talmont E; Speidel JJ; Harper CC
Am J Obstet Gynecol; 2018 Jan; 218(1):107.e1-107.e8. PubMed ID: 28986072
[TBL] [Abstract][Full Text] [Related]
42. Use of long-acting reversible contraception in a cluster-random sample of female sex workers in Kenya.
Ampt FH; Lim MSC; Agius PA; Chersich MF; Manguro G; Gichuki CM; Stoové M; Temmerman M; Jaoko W; Hellard M; Gichangi P; Luchters S
Int J Gynaecol Obstet; 2019 Aug; 146(2):184-191. PubMed ID: 31090059
[TBL] [Abstract][Full Text] [Related]
43. Adolescents' Acceptance of Long-Acting Reversible Contraception After an Educational Intervention in the Emergency Department: A Randomized Controlled Trial.
Vayngortin T; Bachrach L; Patel S; Tebb K
West J Emerg Med; 2020 Apr; 21(3):640-646. PubMed ID: 32421513
[TBL] [Abstract][Full Text] [Related]
44. Women's contraceptive discontinuation and switching behavior in urban Senegal, 2010-2015.
Barden-O'Fallon J; Speizer IS; Calhoun LM; Corroon M
BMC Womens Health; 2018 Feb; 18(1):35. PubMed ID: 29402320
[TBL] [Abstract][Full Text] [Related]
45. Contraceptive discontinuation and pregnancy postabortion in Nepal: a longitudinal cohort study.
Puri M; Henderson JT; Harper CC; Blum M; Joshi D; Rocca CH
Contraception; 2015 Apr; 91(4):301-7. PubMed ID: 25553872
[TBL] [Abstract][Full Text] [Related]
46. The Impact of an Adolescent Gynecology Provider on Intrauterine Device and Subdermal Contraceptive Implant Use Among Adolescent Patients.
Crain CL; DeFruscio AE; Shah PT; Hunt L; Yoost JL
J Pediatr Adolesc Gynecol; 2020 Aug; 33(4):377-381. PubMed ID: 32087404
[TBL] [Abstract][Full Text] [Related]
47. Long-term depot medroxyprogesterone acetate (Depo-Provera) use in inner-city adolescents.
Polaneczky M; Liblanc M
J Adolesc Health; 1998 Aug; 23(2):81-8. PubMed ID: 9714170
[TBL] [Abstract][Full Text] [Related]
48. Can intrauterine device removals for bleeding or pain be predicted at a one-month follow-up visit? A multivariate analysis.
Stanback J; Grimes D
Contraception; 1998 Dec; 58(6):357-60. PubMed ID: 10095972
[TBL] [Abstract][Full Text] [Related]
49. Factors Associated with New Uptake of Long-Acting Reversible Contraceptives Since the Affordable Care Act Among Privately Insured Women in Pennsylvania.
Nelson HN; Thayer E; Bailey C; Leuenberger L; Lehman E; Chuang CH
Womens Health Issues; 2019; 29(5):370-375. PubMed ID: 31337530
[TBL] [Abstract][Full Text] [Related]
50. Obstetrician-gynecologists and contraception: practice and opinions about the use of IUDs in nulliparous women, adolescents and other patient populations.
Luchowski AT; Anderson BL; Power ML; Raglan GB; Espey E; Schulkin J
Contraception; 2014 Jun; 89(6):572-7. PubMed ID: 24679477
[TBL] [Abstract][Full Text] [Related]
51. Hormonally impregnated intrauterine systems (IUSs), versus other forms of reversible contraceptives as effective methods of preventing pregnancy.
French R; Cowan F; Mansour D; Morris S; Hughes D; Robinson A; Proctor T; Summerbell C; Logan S; Guillebaud J
Cochrane Database Syst Rev; 2001; (2):CD001776. PubMed ID: 11406007
[TBL] [Abstract][Full Text] [Related]
52. Expanding Access to the Intrauterine Device in Public Health Facilities in Ethiopia: A Mixed-Methods Study.
Tilahun Y; Mehta S; Zerihun H; Lew C; Brooks MI; Nigatu T; Hagos KL; Asnake M; Tasissa A; Ali S; Desalegn K; Adane G
Glob Health Sci Pract; 2016 Mar; 4(1):16-28. PubMed ID: 27016541
[TBL] [Abstract][Full Text] [Related]
53. Intrauterine device continuation rates and reasons for discontinuation in a Central European clinic with a high standard of care and ultrasound follow-up: a retrospective cohort study.
Bachofner M; Blickenstorfer K; Hutmacher J; Wehrle L; Leeners B; Merki-Feld G
Eur J Contracept Reprod Health Care; 2018 Dec; 23(6):407-414. PubMed ID: 30628516
[TBL] [Abstract][Full Text] [Related]
54. The comparative trial of TCu 380A IUD and progesterone-releasing vaginal ring used by lactating women.
Chen JH; Wu SC; Shao WQ; Zou MH; Hu J; Cong L; Miao L; Wang C; Dong J; Gao J; Xiao BL
Contraception; 1998 Jun; 57(6):371-9. PubMed ID: 9693396
[TBL] [Abstract][Full Text] [Related]
55. Predictors of Early Discontinuation of Effective Contraception by Teens at High Risk of Pregnancy.
Maslyanskaya S; Coupey SM; Chhabra R; Khan UI
J Pediatr Adolesc Gynecol; 2016 Jun; 29(3):269-75. PubMed ID: 26526036
[TBL] [Abstract][Full Text] [Related]
56. Long-term utilization and continuation of intrauterine devices.
Diedrich JT; Madden T; Zhao Q; Peipert JF
Am J Obstet Gynecol; 2015 Dec; 213(6):822.e1-6. PubMed ID: 26409157
[TBL] [Abstract][Full Text] [Related]
57. Return of fertility after discontinuation of depot medroxyprogesterone acetate and intra-uterine devices in Northern Thailand.
Pardthaisong T; Gray RH; McDaniel EB
Lancet; 1980 Mar; 1(8167):509-12. PubMed ID: 6102234
[TBL] [Abstract][Full Text] [Related]
58. Funding policies and postabortion long-acting reversible contraception: results from a cluster randomized trial.
Rocca CH; Thompson KM; Goodman S; Westhoff CL; Harper CC
Am J Obstet Gynecol; 2016 Jun; 214(6):716.e1-8. PubMed ID: 26692178
[TBL] [Abstract][Full Text] [Related]
59. Immediate postplacental insertion of GYNE-T 380 and GYNE-T 380 postpartum intrauterine contraceptive devices: randomized study.
Tatum HJ; Beltran RS; Ramos R; Van Kets H; Sivin I; Schmidt FH
Am J Obstet Gynecol; 1996 Nov; 175(5):1231-5. PubMed ID: 8942493
[TBL] [Abstract][Full Text] [Related]
60. Rates and outcomes of planned pregnancy after use of Norplant capsules, Norplant II rods, or levonorgestrel-releasing or copper TCu 380Ag intrauterine contraceptive devices.
Sivin I; Stern J; Diaz S; Pavéz M; Alvarez F; Brache V; Mishell DR; Lacarra M; McCarthy T; Holma P
Am J Obstet Gynecol; 1992 Apr; 166(4):1208-13. PubMed ID: 1566771
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
